Search Results for: geron

A crazy week for stem cells: what the heck does it all mean?

This past week was a wacky and wild one for the stem cell field. All kinds of crazy things happened all in one week. What does it all mean? Stem cells the new steroids for sports? Reports surface this week that NY Yankees pitcher Bartolo Colon, had received a non-FDA approved stem cell treatment for …

A crazy week for stem cells: what the heck does it all mean? Read More »

Why invest in stem cells? Progress, Patients, and Patents

Ideas are the foundation of stem cell research, but funding makes those ideas a reality. We talk a lot about governmental funding of stem cell research through CIRM and NIH. The funding from these agencies is essential and will undoubtedly lead to new treatments and cures, possibly for millions of patients. But there is another …

Why invest in stem cells? Progress, Patients, and Patents Read More »

Challenges translating stem cell treatments to patients

Geron-300x2212

It has been a rollercoaster few months between the anti-hESC court cases as well as Geron and Advanced Cell Technology (ACT) receiving the OK from the FDA to proceed with initial clinical trials of stem cell treatments. It’s OK to be excited about the clinical trials and I for one am, but we have to …

Challenges translating stem cell treatments to patients Read More »

Great news: FDA gives ACT the green light bringing hope to millions of people with blindness

advanced-cell-technology

The FDA has given Advanced Cell Technology (ACT) the go ahead to begin their clinical trial using retinal progenitor cells derived from hESC by clearing the company’s IND application, bringing hope to those with vision loss and even blindness. The trial will be a combined Phase I/II to treat Stargardt’s Macular Dystrophy and has huge …

Great news: FDA gives ACT the green light bringing hope to millions of people with blindness Read More »

Not ready for prime time: the three critical challenges for IPS cells

FaviconIPSCELL

If IPS cells are not ready for prime time, it is probably due to these three critical challenges for these amazing cells. TUMORIGENICITY Those of us who work with IPS cells are very excited about their potential for use in regenerative medicine therapies. One serious hurdle we have talked about in the past is tumorigenicity. …

Not ready for prime time: the three critical challenges for IPS cells Read More »